Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
AI Advances Aim to Accelerate Drug Development and Clinical Trials

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Technology

AI Advances Aim to Accelerate Drug Development and Clinical Trials

Analysed 17 Nov 2026·3 sources analysed·Bangalore, India·Technology
AI Advances Aim to Accelerate Drug Development and Clinical TrialsNext

Biocon's Kiran Mazumdar-Shaw highlighted at Bengaluru Tech Summit 2026 that AI could reduce drug development time from five to seven years to one or two years by improving discovery and clinical trial processes. Meanwhile, Alphabet's Isomorphic Labs raised $5 billion to advance AI-driven drug design, nearing preclinical studies for oncology programs and aiming to scale drug development. Both emphasize AI's potential to transform precision medicine and accelerate clinical trials, with validation in trials remaining essential.

Sentiment
73%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (73/100). Lens Score 47/100.

Outlets measured: businessstandard, moneycontrol, ndtv. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 17 Nov 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (73/100)

Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

ndtv broke this story on 17 Nov, 04:21 pm. Other outlets followed.

17 Nov, 04:21 pm3 sources · 2 h17 Nov, 05:56 pm
AI analysis by the TBN Bias Engine · beat methodology byAshwin Alsi· Technology Editor· editorial standards byOjas Kale
Next →
Widespread Disruptions Reported Across Multiple Apple Services
  1. 1
    ndtv17 Nov, 04:21 pm
    Alphabet's Isomorphic Labs Raises 5 Billion In Sequoia-Led Funding Round
  2. 2
    moneycontrol17 Nov, 05:41 pm
    Artificial Intelligence might help cut drug development time from 5-7 years to 1-2 years: Kiran Mazumdar-Shaw- Moneycontrol.com
  3. 3
    businessstandard17 Nov, 05:56 pm
    AI may cut drug development time, says Biocon's Kiran Mazumdar-Shaw

Who's involved

Institutions and figures named across source coverage.

Government
Government of Karnataka
Corporate
GoogleThrive CapitalNvidia CorporationEli Lilly and CompanyNovartis AGGreenoaks CapitalBiocon LimitedJohnson and JohnsonAndreessen HorowitzGoogle DeepMindSequoia CapitalAlphabet Incorporated

Story context

Category
Tech
Location
Bangalore, India
Sources analysed
3
Last analysed
17 Nov 2026
Key entities
Artificial intelligenceClinical trialKiran Mazumdar-ShawBioconDrug developmentBangalorePersonalized medicineReal-time computingAnalyticsMedical diagnosisBiologyIndia